EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 327 filers reported holding EXELIXIS INC in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,823,107 | +18.8% | 129,204 | +3.9% | 0.10% | +15.6% |
Q2 2023 | $2,376,309 | +116.5% | 124,349 | +119.9% | 0.09% | +95.7% |
Q1 2023 | $1,097,364 | +11.5% | 56,536 | -7.9% | 0.05% | -22.0% |
Q4 2022 | $984,503 | -62.6% | 61,378 | -63.4% | 0.06% | -64.0% |
Q3 2022 | $2,630,000 | +193.2% | 167,726 | +289.4% | 0.16% | +397.0% |
Q2 2022 | $897,000 | +110.6% | 43,077 | +129.3% | 0.03% | +94.1% |
Q1 2022 | $426,000 | -15.6% | 18,785 | -32.0% | 0.02% | -26.1% |
Q4 2021 | $505,000 | -59.6% | 27,632 | -53.2% | 0.02% | -67.6% |
Q3 2021 | $1,249,000 | -32.7% | 59,081 | -42.0% | 0.07% | -40.3% |
Q2 2021 | $1,856,000 | +28.3% | 101,848 | +59.0% | 0.12% | +65.3% |
Q1 2021 | $1,447,000 | +39.7% | 64,050 | +24.1% | 0.07% | +60.0% |
Q4 2020 | $1,036,000 | +226.8% | 51,624 | +298.3% | 0.04% | +200.0% |
Q3 2020 | $317,000 | -73.2% | 12,960 | -74.0% | 0.02% | -75.0% |
Q2 2020 | $1,184,000 | +59.6% | 49,890 | +15.8% | 0.06% | +13.2% |
Q1 2020 | $742,000 | +81.9% | 43,083 | +86.0% | 0.05% | +194.4% |
Q4 2019 | $408,000 | -79.3% | 23,160 | -74.9% | 0.02% | -83.5% |
Q2 2019 | $1,970,000 | +64.2% | 92,201 | +82.9% | 0.11% | +49.3% |
Q1 2019 | $1,200,000 | – | 50,400 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |